Skip to main content

Find Clinical Trials

Home
Conditions
Transthyretin Mediated Amyloidosis (ATTR)

Clinical trial condition

Transthyretin Mediated Amyloidosis (ATTR)

Explore clinical trials studying Transthyretin Mediated Amyloidosis (ATTR). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Transthyretin Mediated Amyloidosis (ATTR) trial results

Not Yet Recruiting

PET/CT Imaging in Carriers of TTR Mutations

NCT07591038

Conditions: ATTR, ATTR Gene Mutation, Amyloidosis, +8 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis

NCT01148953

Conditions: Transthyretin Mediated Amyloidosis (ATTR)
Locations: Clinical Site Le Kremlin-Bicêtre, France

Clinical Site Porto, Portugal

Clinical Site Umeå, Sweden

Clinical Site London, United Kingdom

View Trial Details